ExecPay

Matthew A. Spear

Overview20212020

Overview

Matthew A. Spear received an average of $1M in total compensation, including $436K in salary, at Poseida Therapeutics between 2020 and 2021.

Source: SEC filing on April 27, 2022.
Spear's 2021 pay

Related executives

We found five more executives who work or worked at Poseida Therapeutics.

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

4

Kristin Yarema

Poseida Therapeutics

President, Cell Therapy

1

Brent Warner

Poseida Therapeutics

President, Gene Therapy

2

Eric Ostertag

Poseida Therapeutics

Chief Executive Officer

3

Harry Leonhardt

Poseida Therapeutics

General Counsel

2

News

You may also like

Poseida Therapeutics